{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:07:55Z","timestamp":1790726875232,"version":"4.1.0"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.drup.2020.100720","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T12:23:52Z","timestamp":1597926232000},"page":"100720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"C","title":["Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification"],"prefix":"10.1016","volume":"53","author":[{"given":"Bowen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda G.","family":"Assaraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2020.100720_bib0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2020.100720_bib0010","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1038\/cddis.2012.30","article-title":"Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers","volume":"3","author":"Adar","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2020.100720_bib0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.stem.2015.09.005","article-title":"Coordination of m(6)A mRNA methylation and gene transcription by ZFP217 regulates pluripotency and reprogramming","volume":"17","author":"Aguilo","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0020","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1158\/0008-5472.CAN-14-2356","article-title":"Genetic and pharmacological screens converge in identifying FLIP, BCL2, and IAP proteins as key regulators of sensitivity to the TRAIL-inducing anticancer agent ONC201\/TIC10","volume":"75","author":"Allen","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2020.100720_bib0025","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1158\/2159-8290.CD-13-0014","article-title":"Targeting the BRAF V600E mutation in multiple myeloma","volume":"3","author":"Andrulis","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2020.100720_bib0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drup.2006.09.001","article-title":"The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis","volume":"9","author":"Assaraf","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0035","doi-asserted-by":"crossref","first-page":"100645","DOI":"10.1016\/j.drup.2019.100645","article-title":"The multi-factorial nature of clinical multidrug resistance in cancer","volume":"46","author":"Assaraf","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0040","doi-asserted-by":"crossref","first-page":"a019521","DOI":"10.1101\/cshperspect.a019521","article-title":"Histone modifications and cancer","volume":"8","author":"Audia","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.drup.2020.100720_bib0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/pr.115.011411","article-title":"Role of cytochrome P450 2C8 in drug metabolism and interactions","volume":"68","author":"Backman","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drup.2020.100720_bib0055","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fonc.2019.00332","article-title":"YTHDF1 regulates tumorigenicity and cancer stem cell-like activity in human colorectal carcinoma","volume":"9","author":"Bai","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26116","article-title":"The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline","volume":"6","author":"Bailey","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.drup.2020.100720_bib0065","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.annonc.2020.03.303","article-title":"Extrachromosomal DNA-relieving heredity constraints, accelerating tumour evolution","volume":"31","author":"Bailey","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drup.2017.05.002","article-title":"Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance","volume":"31","author":"Bar-Zeev","year":"2017","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","article-title":"M(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells","volume":"15","author":"Batista","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41576-018-0074-2","article-title":"Clinical epigenetics: seizing opportunities for translation","volume":"20","author":"Berdasco","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drup.2020.100720_bib0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0090","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nm.4091","article-title":"A framework for understanding and targeting residual disease in oncogene-driven solid cancers","volume":"22","author":"Bivona","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0095","article-title":"Small-molecule drug repurposing to target DNA damage repair and response pathways","volume":"27","author":"Brinkman","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0100","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.2147\/OTT.S226796","article-title":"RNA m(6)A methyltransferase METTL3 promotes the growth of prostate cancer by regulating hedgehog pathway","volume":"12","author":"Cai","year":"2019","journal-title":"Onco. Ther."},{"key":"10.1016\/j.drup.2020.100720_bib0105","doi-asserted-by":"crossref","first-page":"100671","DOI":"10.1016\/j.drup.2019.100671","article-title":"Towards the overcoming of anticancer drug resistance mediated by p53 mutations","volume":"49","author":"Cao","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0115","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/s41388-018-0216-1","article-title":"cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage","volume":"37","author":"Castej\u00f3n-Gri\u00f1\u00e1n","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2020.100720_bib0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12916-017-0900-y","article-title":"The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome","volume":"15","author":"Caswell","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.drup.2020.100720_bib0125","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/MD.0000000000004766","article-title":"Cancer stem cells: role in tumor growth, recurrence, metastasis, and treatment resistance","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.drup.2020.100720_bib0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cyto.2018.06.018","article-title":"Methylation of RNA N(6)-methyladenosine in modulation of cytokine responses and tumorigenesis","volume":"118","author":"Chang","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.drup.2020.100720_bib0135","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1021\/ja3064149","article-title":"Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor","volume":"134","author":"Chen","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drup.2020.100720_bib0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.stem.2015.01.016","article-title":"M(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency","volume":"16","author":"Chen","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2020.100720_bib0150","first-page":"1","article-title":"M(6)A mRNA methylation regulates testosterone synthesis through modulating autophagy in leydig cells","author":"Chen","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2020.100720_bib0155","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.celrep.2019.07.032","article-title":"M(6)A RNA methylation maintains hematopoietic stem cell identity and symmetric commitment","volume":"28","author":"Cheng","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2020.100720_bib0160","doi-asserted-by":"crossref","first-page":"101997","DOI":"10.1016\/j.ctrv.2020.101997","article-title":"Targeting complex, adaptive responses in melanoma therapy","volume":"86","author":"Cheng","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.drup.2020.100720_bib0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","article-title":"Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance","volume":"35","author":"Cooper","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0170","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","article-title":"M(6)A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells","volume":"18","author":"Cui","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2020.100720_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.11.001","article-title":"Modulating ROS to overcome multidrug resistance in cancer","volume":"41","author":"Cui","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0180","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/CMR.0000000000000580","article-title":"RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2","volume":"29","author":"Dahal","year":"2019","journal-title":"Melanoma Res."},{"key":"10.1016\/j.drup.2020.100720_bib0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molmed.2019.09.007","article-title":"Nrf2: redox and metabolic regulator of stem cell state and function","volume":"26","author":"Dai","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0190","doi-asserted-by":"crossref","first-page":"100682","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0195","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/onc.2014.42","article-title":"Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of Drosophila epithelial cells","volume":"34","author":"Dekanty","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2020.100720_bib0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drup.2017.02.001","article-title":"Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges","volume":"30","author":"Diesendruck","year":"2017","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0205","article-title":"Chidamide increases the sensitivity of non-small cell lung cancer to crizotinib by decreasing c-MET mRNA methylation","author":"Ding","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.drup.2020.100720_bib0210","doi-asserted-by":"crossref","DOI":"10.3390\/cells7120259","article-title":"Lysosomal sequestration impairs the activity of the preclinical FGFR inhibitor PD173074","volume":"7","author":"Englinger","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.drup.2020.100720_bib0215","unstructured":"Entacapone Combination With Imatinib for Treatment of GIST. https:\/\/ClinicalTrials.gov\/show\/NCT04006769."},{"key":"10.1016\/j.drup.2020.100720_bib0220","doi-asserted-by":"crossref","first-page":"100715","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0225","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drup.2012.10.001","article-title":"From tumor prevention to therapy: empowering p53 to fight back","volume":"15","author":"Frezza","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0230","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1158\/0008-5472.CAN-18-3592","article-title":"N(6)-Methylation of Adenosine of FZD10 mRNA contributes to PARP inhibitor resistance","volume":"79","author":"Fukumoto","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2020.100720_bib0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drup.2018.01.002","article-title":"Redundant angiogenic signaling and tumor drug resistance","volume":"36","author":"Gacche","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0240","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1126\/science.1261417","article-title":"Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation","volume":"347","author":"Geula","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.drup.2020.100720_bib0245","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/0008-5472.CAN-18-2076","article-title":"A DNA repair and cell-cycle gene expression signature in primary and recurrent glioblastoma: prognostic value and clinical implications","volume":"79","author":"Gobin","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2020.100720_bib0250","doi-asserted-by":"crossref","first-page":"e35487","DOI":"10.1371\/journal.pone.0035487","article-title":"Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics","volume":"7","author":"Goler-Baron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2020.100720_bib0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance","volume":"15","author":"Gonen","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0260","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1158\/1078-0432.CCR-11-1667","article-title":"Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance","volume":"17","author":"Gotink","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2020.100720_bib0265","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1200\/JCO.18.02050","article-title":"Moving from poly (ADP-Ribose) polymerase inhibition to targeting DNA repair and DNA damage response in cancer therapy","volume":"37","author":"Gourley","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0270","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/annonc\/mdy057","article-title":"Restoration of conformation of mutant p53","volume":"29","author":"Green","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0275","doi-asserted-by":"crossref","first-page":"109553","DOI":"10.1016\/j.cellsig.2020.109553","article-title":"N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation","volume":"69","author":"Gu","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.drup.2020.100720_bib0280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2011.05.074","article-title":"DNA double-strand break - induced pro-survival signaling","volume":"101","author":"Hawkins","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0285","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1021\/acs.jmedchem.5b00702","article-title":"Identification of a novel small-molecule binding site of the fat mass and obesity associated protein (FTO)","volume":"58","author":"He","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2020.100720_bib0290","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0295","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tibs.2018.04.002","article-title":"Amazing diversity in biochemical roles of Fe(II)\/2-oxoglutarate oxygenases","volume":"43","author":"Herr","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.drup.2020.100720_bib0300","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41467-018-03135-w","article-title":"LEM-3 is a midbody-tethered DNA nuclease that resolves chromatin bridges during late mitosis","volume":"9","author":"Hong","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2020.100720_bib0305","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2020.100720_bib0310","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1007\/s13277-015-4144-1","article-title":"HNRNPC as a candidate biomarker for chemoresistance in gastric cancer","volume":"37","author":"Huang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0315","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0320","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0325","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"M(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0330","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2020.05.007","article-title":"Can CYP Inhibition Overcome Chemotherapy Resistance?","volume":"41","author":"Ingelman-Sundberg","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drup.2020.100720_bib0335","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0340","doi-asserted-by":"crossref","first-page":"100683","DOI":"10.1016\/j.drup.2020.100683","article-title":"Long non-coding RNAs as a determinant of cancer drug resistance: towards the overcoming of chemoresistance via modulation of lncRNAs","volume":"50","author":"Jiang","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0345","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41422-018-0069-8","article-title":"M(6)A RNA modification controls autophagy through upregulating ULK1 protein abundance","volume":"28","author":"Jin","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2020.100720_bib0350","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-019-0830-6","article-title":"M(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis","volume":"12","author":"Jin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0355","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ebiom.2019.07.068","article-title":"N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer","volume":"47","author":"Jin","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drup.2020.100720_bib0360","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/17425255.2015.1028356","article-title":"Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism","volume":"11","author":"Joyce","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.drup.2020.100720_bib0365","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/leu.2011.35","article-title":"The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress","volume":"25","author":"Kamranvar","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2020.100720_bib0370","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drup.2020.100720_bib0375","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1535-7163.MCT-13-0743","article-title":"Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study","volume":"13","author":"Kathawala","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2020.100720_bib0380","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5732\/cjc.013.10122","article-title":"Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs","volume":"33","author":"Kathawala","year":"2014","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.drup.2020.100720_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","article-title":"The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade","volume":"18","author":"Kathawala","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0390","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2019.07.004","article-title":"Immune checkpoint inhibitor combinations: current efforts and important aspects for success","volume":"45","author":"Kon","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0400","doi-asserted-by":"crossref","first-page":"105731","DOI":"10.1016\/j.biocel.2020.105731","article-title":"Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells","volume":"122","author":"Kong","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0405","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1261\/rna.064238.117","article-title":"The m(6)A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5\u2019-3\u2019 exoribonuclease XRN1","volume":"24","author":"Kretschmer","year":"2018","journal-title":"Rna"},{"key":"10.1016\/j.drup.2020.100720_bib0410","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature14267","article-title":"eIF3 targets cell-proliferation messenger RNAs for translational activation or repression","volume":"522","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drup.2020.100720_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.11.002","article-title":"MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: current implications and future directions","volume":"42","author":"Leonetti","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0420","doi-asserted-by":"crossref","first-page":"100644","DOI":"10.1016\/j.drup.2019.100644","article-title":"Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer","volume":"46","author":"Leonetti","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0425","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0430","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature23450","article-title":"M(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways","volume":"548","author":"Li","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2020.100720_bib0435","doi-asserted-by":"crossref","first-page":"15166","DOI":"10.1038\/ncomms15166","article-title":"A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2020.100720_bib0440","doi-asserted-by":"crossref","first-page":"96103","DOI":"10.18632\/oncotarget.21726","article-title":"The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2020.100720_bib0445","series-title":"IDDF2018-ABS-0233 N6-Adenosine Methyltransferase METTL3 Promotes Tumour Metastasis Via SOX2 MRNA M6A Modification in Colorectal Carcinoma","author":"Li","year":"2018"},{"key":"10.1016\/j.drup.2020.100720_bib0450","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020296","article-title":"N6-methyladenosine regulates the expression and secretion of TGFbeta1 to affect the epithelial-mesenchymal transition of cancer cells","volume":"9","author":"Li","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.drup.2020.100720_bib0455","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m(6)A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0460","doi-asserted-by":"crossref","first-page":"e103181","DOI":"10.15252\/embj.2019103181","article-title":"RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy","volume":"39","author":"Lin","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2020.100720_bib0465","doi-asserted-by":"crossref","first-page":"e50097","DOI":"10.15252\/embr.202050097","article-title":"Linking m(6) A to Wnt signaling","volume":"21","author":"Liu","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drup.2020.100720_bib0470","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature14234","article-title":"N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions","volume":"518","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drup.2020.100720_bib0475","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","article-title":"M(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer","volume":"20","author":"Liu","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0480","doi-asserted-by":"crossref","first-page":"111894","DOI":"10.1016\/j.yexcr.2020.111894","article-title":"FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13","volume":"389","author":"Liu","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.drup.2020.100720_bib0485","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.addr.2013.08.006","article-title":"Rationally designed nanovehicles to overcome cancer chemoresistance","volume":"65","author":"Livney","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drup.2020.100720_bib0490","doi-asserted-by":"crossref","first-page":"100703","DOI":"10.1016\/j.drup.2020.100703","article-title":"Genetic biomarkers of drug resistance: a compass of prognosis and targeted therapy in acute myeloid leukemia","volume":"52","author":"Long","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0495","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1002\/jcp.29608","article-title":"RNA m(6) A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c-Met","volume":"235","author":"Luo","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.drup.2020.100720_bib0500","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/cr.2017.143","article-title":"Endothelial-specific m(6)A modulates mouse hematopoietic stem and progenitor cell development via Notch signaling","volume":"28","author":"Lv","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2020.100720_bib0505","doi-asserted-by":"crossref","first-page":"115300","DOI":"10.1016\/j.bmc.2019.115300","article-title":"3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line","volume":"28","author":"Malacrida","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drup.2020.100720_bib0510","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/17425247.2016.1214565","article-title":"Transporter effects on cell permeability in drug delivery","volume":"14","author":"Mandal","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.drup.2020.100720_bib0515","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0520","unstructured":"Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary. https:\/\/ClinicalTrials.gov\/show\/NCT02429570."},{"key":"10.1016\/j.drup.2020.100720_bib0525","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw8828","article-title":"Overcoming adaptive therapy resistance in AML by targeting immune response pathways","volume":"11","author":"Melgar","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0530","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41397-019-0110-4","article-title":"Dissecting the m(6)A methylation affection on afatinib resistance in non-small cell lung cancer","volume":"20","author":"Meng","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.drup.2020.100720_bib0535","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","article-title":"The roles of DNA, RNA and histone methylation in ageing and cancer","volume":"20","author":"Michalak","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0540","first-page":"363","article-title":"Cancer treatment and survivorship statistics","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2020.100720_bib0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2019.07.003","article-title":"Exosomes and their role in tumorigenesis and anticancer drug resistance","volume":"45","author":"Milman","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0550","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jtho.2018.03.013","article-title":"Concurrent acquired BRAF V600E mutation and MET amplification as resistance mechanism of first-line osimertinib treatment in a patient with EGFR-Mutated NSCLC","volume":"13","author":"Minari","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0555","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2016.03.002","article-title":"Repositioning of drugs for intervention in tumor progression and metastasis: old drugs for new targets","volume":"26","author":"Mudduluru","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0560","doi-asserted-by":"crossref","first-page":"113697","DOI":"10.1016\/j.bcp.2019.113697","article-title":"Methylation of adenosine at the N(6) position post-transcriptionally regulates hepatic P450s expression","volume":"171","author":"Nakano","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2020.100720_bib0565","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/1535-7163.MCT-16-0522","article-title":"MET copy number gain is associated with gefitinib resistance in leptomeningeal carcinomatosis of EGFR-mutant lung cancer","volume":"16","author":"Nanjo","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2020.100720_bib0570","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.drup.2019.100663","article-title":"Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance","volume":"48","author":"Narayanan","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0575","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41588-018-0287-5","article-title":"Acquired HER2 mutations in ER metastatic breast cancer confer resistance to estrogen receptor-directed therapies","volume":"51","author":"Nayar","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drup.2020.100720_bib0580","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx059","article-title":"Drugging the cancers addicted to DNA repair","volume":"109","author":"Nickoloff","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2020.100720_bib0585","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.drup.2014.12.001","article-title":"Molecular basis of resistance to proteasome inhibitors in hematological malignancies","volume":"18","author":"Niewerth","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0590","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.apsb.2018.06.001","article-title":"N (6)-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development","volume":"8","author":"Niu","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drup.2020.100720_bib0595","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nm.4038","article-title":"CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma","volume":"22","author":"Noll","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0600","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O\u2019Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0605","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1074\/jbc.RA118.006944","article-title":"EGF receptor and PKC\u03b4 kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases","volume":"294","author":"Ohm","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2020.100720_bib0610","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1158\/1078-0432.CCR-15-1915","article-title":"Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors","volume":"22","author":"Ortiz-Cuaran","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2020.100720_bib0615","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamaoncol.2018.2969","article-title":"Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-Positive lung cancer and acquired resistance to osimertinib","volume":"4","author":"Oxnard","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0620","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2741\/s350","article-title":"Cytochrome P450 in non-small cell lung cancer related to exogenous chemical metabolism","volume":"4","author":"Oyama","year":"2012","journal-title":"Front. Biosci. (Schol Ed)"},{"key":"10.1016\/j.drup.2020.100720_bib0625","doi-asserted-by":"crossref","first-page":"280","DOI":"10.15252\/embr.201439949","article-title":"Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure","volume":"16","author":"Pagliarini","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drup.2020.100720_bib0630","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7116","article-title":"Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1","volume":"11","author":"Peng","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0635","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13046-019-1408-4","article-title":"Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246\/SPRED2\/MAPK signaling pathway","volume":"38","author":"Peng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2020.100720_bib0640","doi-asserted-by":"crossref","first-page":"100718","DOI":"10.1016\/j.drup.2020.100718","article-title":"Cancer immunotherapy resistance based on immune checkpoints inhibitors: targets, biomarkers, and remedies","volume":"53","author":"P\u00e9rez-Ruiz","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0645","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/15548627.2016.1245263","article-title":"Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia","volume":"13","author":"Piya","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2020.100720_bib0650","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798804","article-title":"The complex relationship between TFEB transcription factor phosphorylation and subcellular localization","volume":"37","author":"Puertollano","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2020.100720_bib0655","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","article-title":"Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma","volume":"28","author":"Qazi","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0660","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1021\/acs.biochem.6b00023","article-title":"A novel inhibitor of the obesity-related protein FTO","volume":"55","author":"Qiao","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2020.100720_bib0665","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-019-0992-4","article-title":"Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment","volume":"18","author":"Qu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2020.100720_bib0670","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1074\/jbc.RA118.004671","article-title":"p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells","volume":"294","author":"Rangel","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2020.100720_bib0675","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drup.2016.06.004","article-title":"Folylpoly-\u03b3-glutamate synthetase: a key determinant of folate homeostasis and antifolate resistance in cancer","volume":"28","author":"Raz","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0680","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a004762","article-title":"Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study","volume":"6","author":"Restrepo","year":"2020","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"10.1016\/j.drup.2020.100720_bib0685","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tig.2017.04.003","article-title":"M(6)A in mRNA: an ancient mechanism for fine-tuning gene expression","volume":"33","author":"Roignant","year":"2017","journal-title":"Trends Genet."},{"key":"10.1016\/j.drup.2020.100720_bib0690","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2020.100720_bib0695","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.drup.2020.100720_bib0700","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molmed.2018.12.009","article-title":"Principles of resistance to targeted cancer therapy: lessons from basic and translational Cancer biology","volume":"25","author":"Sabnis","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0705","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired resistance to immune checkpoint inhibitors","volume":"37","author":"Schoenfeld","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0710","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","article-title":"Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance","volume":"25","author":"Seguin","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0715","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.celrep.2019.02.100","article-title":"Discovery of small molecules that activate RNA methylation through cooperative binding to the METTL3-14-WTAP complex active site","volume":"26","author":"Selberg","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2020.100720_bib0720","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.26855","article-title":"Levodopa-entacapone-carbidopa intestinal gel in Parkinson\u2019s disease: a randomized crossover study","volume":"32","author":"Senek","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.drup.2020.100720_bib0725","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drup.2011.01.003","article-title":"Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance","volume":"14","author":"Shapira","year":"2011","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0730","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","article-title":"Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy","volume":"4","author":"Shi","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2020.100720_bib0735","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2020.100720_bib0740","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0745","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1038\/s41467-019-12801-6","article-title":"YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression","volume":"10","author":"Shi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2020.100720_bib0750","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10495-020-01591-8","article-title":"DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m(6)A-demethylation of FOXM1 and NANOG","volume":"25","author":"Shriwas","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.drup.2020.100720_bib0755","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-019-0259-4","article-title":"Microenvironment plasticity confers cetuximab resistance","volume":"16","author":"Sidaway","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0760","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/onc.2017.279","article-title":"RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance","volume":"36","author":"Somasagara","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2020.100720_bib0765","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1080\/15548627.2019.1586246","article-title":"METTL3 and ALKBH5 oppositely regulate m(6)A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes","volume":"15","author":"Song","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2020.100720_bib0770","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11255-011-0012-0","article-title":"Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: a preclinical evaluation","volume":"44","author":"Soriano-Hernandez","year":"2012","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.drup.2020.100720_bib0775","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3892\/ol.2015.3580","article-title":"Anti-inflammatory drugs and uterine cervical cancer cells: antineoplastic effect of meclofenamic acid","volume":"10","author":"Soriano-Hernandez","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.drup.2020.100720_bib0780","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semcancer.2018.11.006","article-title":"Therapy resistance mediated by cancer stem cells","volume":"53","author":"Steinbichler","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0785","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drup.2018.05.001","article-title":"How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance","volume":"38","author":"Stiewe","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0790","first-page":"e225","article-title":"circMORC3 contributes to cisplatin-resistance by affecting M6A modification on DNA damage response related genes in bladder cancer","volume":"203","author":"Su","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.drup.2020.100720_bib0795","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0800","series-title":"Effective Novel Fto Inhibitors Show Potent Anti-Cancer Efficacy and Suppress Drug Resistance","author":"Su","year":"2019"},{"key":"10.1016\/j.drup.2020.100720_bib0805","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","article-title":"TGF-\u03b2 orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1","volume":"577","author":"Su","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drup.2020.100720_bib0810","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2015.07.044","article-title":"Tumor microenvironment and cancer therapy resistance","volume":"380","author":"Sun","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2020.100720_bib0815","first-page":"621","article-title":"The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0820","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1002\/ijc.32677","article-title":"ANKLE1 N(6) -Methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability","volume":"146","author":"Tian","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2020.100720_bib0825","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.drup.2020.100720_bib0830","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1039\/C4SC02554G","article-title":"A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N(6)-methyladenosine demethylase FTO","volume":"6","author":"Toh","year":"2015","journal-title":"Chem. Sci."},{"key":"10.1016\/j.drup.2020.100720_bib0835","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/cr.2018.7","article-title":"M(6)A mRNA methylation sustains Treg suppressive functions","volume":"28","author":"Tong","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2020.100720_bib0840","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1158\/1541-7786.MCR-11-0592","article-title":"Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair","volume":"10","author":"Toulany","year":"2012","journal-title":"Mol. Cancer Res.: MCR"},{"key":"10.1016\/j.drup.2020.100720_bib0845","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3389\/fonc.2019.01148","article-title":"Immune system evasion as hallmark of melanoma progression: the role of dendritic cells","volume":"9","author":"Tucci","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2020.100720_bib0850","series-title":"Pharmacological Inhibition of the RNA m6a Writer METTL3 As a Novel Therapeutic Strategy for Acute Myeloid Leukemia","author":"Tzelepis","year":"2019"},{"key":"10.1016\/j.drup.2020.100720_bib0855","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcp.2018.12.014","article-title":"An N(6)-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells","volume":"160","author":"Uddin","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2020.100720_bib0860","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41556-018-0258-1","article-title":"Chromatin regulatory mechanisms and therapeutic opportunities in cancer","volume":"21","author":"Valencia","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0865","doi-asserted-by":"crossref","first-page":"100647","DOI":"10.1016\/j.drup.2019.100647","article-title":"Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance","volume":"47","author":"Vasconcelos","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0870","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/onc.2017.351","article-title":"Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance","volume":"37","author":"Visvanathan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2020.100720_bib0875","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drup.2020.100720_bib0880","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0885","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2016.11.002","article-title":"New strategies for targeting drug combinations to overcome mutation-driven drug resistance","volume":"42","author":"Wang","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2020.100720_bib0890","doi-asserted-by":"crossref","first-page":"98918","DOI":"10.18632\/oncotarget.22041","article-title":"Reduced m(6)A mRNA methylation is correlated with the progression of human cervical cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2020.100720_bib0895","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41422-018-0082-y","article-title":"Loss of YTHDF2-mediated m(6)A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2020.100720_bib0900","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1021\/acs.molpharmaceut.8b00522","article-title":"Identification of natural compound radicicol as a potent FTO inhibitor","volume":"15","author":"Wang","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drup.2020.100720_bib0905","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","article-title":"Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2020.100720_bib0910","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fphar.2019.00517","article-title":"METTL3\/m(6)A\/miRNA-873-5p attenuated oxidative stress and apoptosis in colistin-induced kidney injury by modulating Keap1\/Nrf2 pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drup.2020.100720_bib0915","first-page":"1","article-title":"M(6)A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7","author":"Wang","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2020.100720_bib0920","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2217\/epi-2019-0262","article-title":"Integrated analysis of transcriptome-wide m(6)A methylome of osteosarcoma stem cells enriched by chemotherapy","volume":"11","author":"Wang","year":"2019","journal-title":"Epigenomics"},{"key":"10.1016\/j.drup.2020.100720_bib0925","doi-asserted-by":"crossref","first-page":"144076","DOI":"10.1016\/j.gene.2019.144076","article-title":"N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2","volume":"722","author":"Wang","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.drup.2020.100720_bib0930","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.apsb.2019.09.011","article-title":"Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drup.2020.100720_bib0935","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2020.01.042","article-title":"The m6A methyltransferase METTL3 contributes to transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB","volume":"524","author":"Wanna-Udom","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2020.100720_bib0940","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.15252\/embr.201744940","article-title":"Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs","volume":"18","author":"Warda","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drup.2020.100720_bib0945","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","article-title":"Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal","volume":"69","author":"Wen","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0950","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drup.2020.100720_bib0955","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nri3896","article-title":"Emerging cytokine networks in colorectal cancer","volume":"15","author":"West","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2020.100720_bib0960","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drup.2016.07.001","article-title":"Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics","volume":"28","author":"Wijdeven","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib0965","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026070","article-title":"p53 in the DNA-Damage-Repair process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.drup.2020.100720_bib0970","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.trecan.2020.03.011","article-title":"Emerging mechanisms by which EMT programs control stemness","volume":"6","author":"Wilson","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2020.100720_bib0975","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41590-018-0275-z","article-title":"M(6)A modification controls the innate immune response to infection by targeting type I interferons","volume":"20","author":"Winkler","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2020.100720_bib0980","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1089\/scd.2016.0062","article-title":"N(6)-Methyladenosine methyltransferases and demethylases: new regulators of stem cell pluripotency and differentiation","volume":"25","author":"Wu","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.drup.2020.100720_bib0985","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41467-017-02770-z","article-title":"Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2\/B1","volume":"9","author":"Wu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2020.100720_bib0990","doi-asserted-by":"crossref","first-page":"152666","DOI":"10.1016\/j.prp.2019.152666","article-title":"The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion","volume":"215","author":"Xia","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.drup.2020.100720_bib0995","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nature21671","article-title":"RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response","volume":"543","author":"Xiang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2020.100720_bib1000","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2020.100720_bib1005","doi-asserted-by":"crossref","DOI":"10.2174\/1574892815666200630102344","article-title":"Recent patents on the development of c-Met kinase inhibitors","author":"Xu","year":"2020","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.drup.2020.100720_bib1010","doi-asserted-by":"crossref","first-page":"17299","DOI":"10.1074\/jbc.M114.550350","article-title":"Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation","volume":"289","author":"Xu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2020.100720_bib1015","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41422-018-0097-4","article-title":"A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors","volume":"28","author":"Yan","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2020.100720_bib1020","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1074\/jbc.M116.749689","article-title":"MicroRNA-145 modulates N(6)-Methyladenosine levels by targeting the 3\u2019-Untranslated mRNA region of the N(6)-methyladenosine binding YTH domain family 2 protein","volume":"292","author":"Yang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2020.100720_bib1025","article-title":"ALKBH5 holds prognostic values and inhibits the metastasis of colon cancer","author":"Yang","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.drup.2020.100720_bib1030","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","article-title":"M(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2020.100720_bib1035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2020.100720_bib1040","article-title":"m6A reader YTHDF2 regulates LPS-induced inflammatory response","volume":"20","author":"Yu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2020.100720_bib1045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11010-019-03641-5","article-title":"The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling","volume":"463","author":"Yu","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.drup.2020.100720_bib1050","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2020.100720_bib1055","first-page":"E2047","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m(6)A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drup.2020.100720_bib1060","first-page":"3936","article-title":"Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets","volume":"27","author":"Zhang","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drup.2020.100720_bib1065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41419-018-0463-7","article-title":"APR-246 reactivates mutant p53 by targeting cysteines 124 and 277","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2020.100720_bib1070","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3389\/fimmu.2019.00922","article-title":"A Review in Research Progress Concerning m6A Methylation and Immunoregulation","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2020.100720_bib1075","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1002\/cam4.2360","article-title":"Reduced m6A modification predicts malignant phenotypes and augmented Wnt\/PI3K-Akt signaling in gastric cancer","volume":"8","author":"Zhang","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.drup.2020.100720_bib1080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41389-020-0229-9","article-title":"TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the \u03b2-catenin\/ABCC9 axis via p62-selective autophagic degradation of Daple","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.drup.2020.100720_bib1085","article-title":"Dexmedetomidine postconditioning alleviates hypoxia\/reoxygenation injury in senescent myocardial cells by regulating lncRNA H19 and m6A modification","volume":"2020","author":"Zhang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.drup.2020.100720_bib1090","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fphar.2018.01312","article-title":"ABCC10 plays a significant role in the transport of gefitinib and contributes to acquired resistance to gefitinib in NSCLC","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drup.2020.100720_bib1095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2020.100720_bib1100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/cn500042t","article-title":"Synthesis of a FTO inhibitor with anticonvulsant activity","volume":"5","author":"Zheng","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.drup.2020.100720_bib1105","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ni.3830","article-title":"The RNA helicase DDX46 inhibits innate immunity by entrapping m(6)A-demethylated antiviral transcripts in the nucleus","volume":"18","author":"Zheng","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2020.100720_bib1110","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1158\/0008-5472.CAN-19-0799","article-title":"Long noncoding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p\/miR-1275 and upregulate ITGB3","volume":"79","author":"Zheng","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2020.100720_bib1115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.18632\/oncotarget.2732","article-title":"Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance","volume":"6","author":"Zhitomirsky","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2020.100720_bib1120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drup.2015.11.004","article-title":"Lysosomes as mediators of drug resistance in cancer","volume":"24","author":"Zhitomirsky","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2020.100720_bib1125","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41419-018-1227-0","article-title":"Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity","volume":"9","author":"Zhitomirsky","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2020.100720_bib1130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/mol.119.117978","article-title":"Wnt signaling and drug resistance in cancer","volume":"97","author":"Zhong","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drup.2020.100720_bib1135","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","article-title":"YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma","volume":"442","author":"Zhong","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2020.100720_bib1140","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.celrep.2017.08.027","article-title":"Genome-Wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs","volume":"20","author":"Zhou","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2020.100720_bib1145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-017-0624-9","article-title":"The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2020.100720_bib1150","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mc.22782","article-title":"FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation","volume":"57","author":"Zhou","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.drup.2020.100720_bib1155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molcel.2019.07.005","article-title":"Regulation of Co-transcriptional pre-mRNA splicing by m(6)A through the low-complexity protein hnRNPG","volume":"76","author":"Zhou","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2020.100720_bib1160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13046-018-1021-y","article-title":"Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage","volume":"38","author":"Zhou","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.drup.2020.100720_bib1165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13046-019-1159-2","article-title":"ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2","volume":"38","author":"Zhu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2020.100720_bib1170","article-title":"Pan-cancer analysis reveals m6A modification is functionally important in cancer","author":"Zuo","year":"2018","journal-title":"AACR"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764620300492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764620300492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:57:43Z","timestamp":1761281863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764620300492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":234,"alternative-id":["S1368764620300492"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2020.100720","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2020.100720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100720"}}